The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

The trials for Moderna's mRESVIA vaccine, which uses the same mRNA technology as the company's Covid-19 shot, did not show ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The CDC lowered the age for the pneumonia vaccination from 65 to 50 and recommended an extra COVID shot to some people.

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...